ProCE Banner Activity


ASCO 2022: What’s New in Mantle Cell Lymphoma

Podcast Episodes

In this podcast episode, listen to Tycel J. Phillips, MD, and Amy Goodrich, MSN, NP-AC, discuss key data for mantle cell lymphoma presented at the 2022 ASCO annual meeting, including data on BTK inhibitors, CAR T-cell therapy, and other novel agents targeting ROR1.

Registered Nurses: 0.50 Nursing contact hours, includes 0.50 hour of pharmacology credit Physician Assistants: maximum of 0.50 hours of AAPA Category 1 CME credits

Released: June 30, 2022

Expiration: June 29, 2023

No longer available for credit.
Begin Activity



Amy Goodrich

Amy Goodrich, MSN-CRNP-AC

Nurse Practitioner
Johns Hopkins School of Medicine
Johns Hopkins Kimmel Cancer Center
Baltimore, Maryland

Tycel J. Phillips

Tycel J. Phillips, MD

Associate Professor of Medicine 
Maria Reinhardt Decesare Research Professor of Blood Cancers and Bone Marrow Transplantation
Hematology and Bone Marrow Transplantation 
City of Hope National Medical Center
Duarte, California 


This activity is supported by an educational grant from Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.

Provided by

ProCE Banner


Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Pharmacyclics LLC, an AbbVie Company

Target Audience

Oncology NPs, PAs and nurses

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Identify recent practice-changing data in the management of MCL

  • Describe strategies for management and monitoring of patients with MCL based on the most current efficacy and safety evidence


Tycel J. Phillips, MD: consultant/advisor/speaker: AbbVie, ADC Therapeutics, AstraZeneca, Bayer, Beigene, Bristol-Myers Squibb, Eli Lilly, Epizyme, Genentech, Genmab, Gilead, Incyte, TG Therapeutics.

Amy Goodrich, MSN, NP-AC, has no relevant financial relationships to disclose.

None of the members of the Planning Committee or PCE staff have any relevant financial relationships to disclose.

Instructions for Credit

Participants wishing to earn CE/CME credit must:

  1. Listen to the content in its entirety
  2. Relate the content material to the learning objectives
  3. Complete the post-test and evaluation form

Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of 100%.

The estimated time to complete this activity is 0.50 hours.

Release date: June 30, 2022
Expiration date: June 29, 2023





Joint Accreditation Statement

Joint AccreditationIn support of improving patient care, Practicing Clinicians Exchange is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

ANCC Credit Designation

Nursing contact hours: 0.50, which includes 0.50 hours of pharmacology credit

AAPA Credit Designation

Joint AccreditationPracticing Clinicians Exchange has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.50 AAPA Category 1 CME credits. Approval is valid until June 29, 2023. PAs should only claim credit commensurate with the extent of their participation.

PA course advisor: Jessica Garner, DMSc, PA-C, University of the Pacific, Sacramento, California

IPCE Credit Designation
IPCEThis activity was planned by and for the healthcare team, and learners will receive 0.50 Interprofessional Continuing Education (IPCE) credits for learning and change.

Additional Information

Program Medium

This program has been made available online.